Next Quarterly Earnings
Tuesday, August 4, 2026
CW 32
Pre-Market
In 30 days
Repligen is a leading US-based company providing innovative bioprocessing technologies for biopharmaceutical development and manufacturing. Specializing in filtration, chromatography, and cell culture media, Repligen delivers essential solutions and single-use systems for global life sciences. The company supports increased efficiency in biopharmaceutical production.